MYCELX Technologies Corporation
MYX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £9 | £10 | £18 | £18 |
| - Cash | £1 | £1 | £2 | £0 |
| + Debt | £1 | £1 | £1 | £1 |
| Enterprise Value | £9 | £10 | £17 | £19 |
| Revenue | £2 | £1 | £4 | £5 |
| % Growth | 19% | -59.9% | -34.4% | – |
| Gross Profit | £1 | £0 | £1 | £1 |
| % Margin | 41.7% | 25.5% | 28.2% | 25.7% |
| EBITDA | -£2 | -£2 | -£2 | -£2 |
| % Margin | -114.5% | -161.4% | -54% | -29.8% |
| Net Income | -£2 | -£1 | -£1 | -£2 |
| % Margin | -114.7% | -97.1% | -38.9% | -41.2% |
| EPS Diluted | -0.08 | -0.06 | -0.059 | -0.096 |
| % Growth | -33.3% | -1.4% | 38.2% | – |
| Operating Cash Flow | -£1 | -£2 | -£1 | -£1 |
| Capital Expenditures | -£0 | £0 | -£0 | -£0 |
| Free Cash Flow | -£1 | -£2 | -£1 | -£1 |